Literature DB >> 21979250

Physicochemical characterization techniques for lipid based delivery systems for siRNA.

Mamta Kapoor1, Diane J Burgess, Siddhesh D Patil.   

Abstract

siRNA based therapeutics is an emerging class of molecules with a high potential for fulfilling the promise of gene medicine. The high selectivity of siRNAs for their targets and subsequent gene ablation has been effectively demonstrated in a wide range of pre-clinical models. siRNA delivery in vivo has been most successfully achieved using lipid-based drug delivery systems. These lipid based formulations are designed to entrap siRNA molecules, ensure stability in in vitro and in vivo milieu, facilitate uptake, enhance cellular targeting, and facilitate delivery in the desired intracellular compartment. As more siRNA-based therapeutics enters the clinic with the associated regulatory scrutiny, there is a clear need to develop well-characterized systems that ensure consistent quality and thus reliable performance. Early clinical trials can be conducted using formulations with limited short-term stability manufactured on a small scale. However, a thorough understanding of the factors that influence the structure and stability of these particulate formulations is required to prevent any issues with optimization of large-scale industrial manufacturing, scale-up, and long-term shelf-life required to support large clinical trials and eventual market use. As newer targets for siRNA are identified and novel lipids are synthesized to optimize their in vivo efficiency, concomitant development of bio-physical methodologies that can improve understanding of the assembly and stability of these complex systems is critical. Along with bio-physical characterization, these assays are also required to reliably design, screen, develop and optimize formulations. Physicochemical characterization thus forms the basis of developing an effective analytical control strategy for siRNA delivery systems. In this review, analytical techniques used to characterize lipid-based siRNA delivery systems are discussed in detail. The importance of these physicochemical characterization techniques and analytical assays is explained. Case studies illustrating their use in siRNA formulation development and optimization are presented. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979250     DOI: 10.1016/j.ijpharm.2011.09.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells.

Authors:  Jean-Rémi Bertrand; Claire Lucas; Ngoc Minh Pham; Catherine Durieu; Patrick Couvreur; Claude Paul Malvy; Didier Desmaële
Journal:  Nucleic Acid Ther       Date:  2015-04-20       Impact factor: 5.486

2.  Cellular uptake mechanisms of novel anionic siRNA lipoplexes.

Authors:  Mamta Kapoor; Diane J Burgess
Journal:  Pharm Res       Date:  2012-12-13       Impact factor: 4.200

3.  Therapeutic silencing of mTOR by systemically administered siRNA-loaded neutral liposomal nanoparticles inhibits DMBA-induced mammary carcinogenesis.

Authors:  Roja Sahu; Shakti Prasad Pattanayak; Shivesh Jha
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

4.  Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.

Authors:  Kohei Kubota; Kohei Onishi; Kazuaki Sawaki; Tianshu Li; Kaoru Mitsuoka; Takaaki Sato; Shinji Takeoka
Journal:  Int J Nanomedicine       Date:  2017-07-19

5.  Construction and Biological Evaluation of a Novel Integrin ανβ₃-Specific Carrier for Targeted siRNA Delivery In Vitro.

Authors:  Xueqi Chen; Meng Liu; Rongfu Wang; Ping Yan; Chunli Zhang; Chao Ma; Lei Yin
Journal:  Molecules       Date:  2017-02-04       Impact factor: 4.411

6.  Positive-charge tuned gelatin hydrogel-siSPARC injectable for siRNA anti-scarring therapy in post glaucoma filtration surgery.

Authors:  Yong Yao Chun; Zhu Li Yap; Li Fong Seet; Hiok Hong Chan; Li Zhen Toh; Stephanie W L Chu; Ying Shi Lee; Tina T Wong; Timothy T Y Tan
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

7.  Physical factors affecting plasmid DNA compaction in stearylamine-containing nanoemulsions intended for gene delivery.

Authors:  André Leandro Silva; Francisco Alexandrino; Lourena Mafra Verissimo; Lucymara Fassarella Agnez-Lima; Lucila Carmem Monte Egito; Anselmo Gomes de Oliveira; Eryvaldo Socrates Tabosa do Egito
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-18

8.  Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

Authors:  Elena Fernández Fernández; Beatriz Santos-Carballal; Chiara de Santi; Joanne M Ramsey; Ronan MacLoughlin; Sally-Ann Cryan; Catherine M Greene
Journal:  Materials (Basel)       Date:  2018-01-13       Impact factor: 3.623

9.  Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape.

Authors:  Anna Lechanteur; Vincent Sanna; Amandine Duchemin; Brigitte Evrard; Denis Mottet; Géraldine Piel
Journal:  Nanomaterials (Basel)       Date:  2018-04-24       Impact factor: 5.076

10.  Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells.

Authors:  Viswanathan Mariammal Berlin Grace; Devarajan David Wilson; Chandrasekharan Guruvayoorappan; Jesubatham Perinba Danisha; Lucia Bonati
Journal:  IET Nanobiotechnol       Date:  2021-03-08       Impact factor: 2.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.